Cancer antigen 15-3 (CA15-3) antibody and antigen (Recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-h-CA15-3-Ag01	Recombinant human MUC1/CA15-3/PUM Protein	3090
GMP-h-CA15-3-Ab01	Anti-human MUC1/CA15-3/PUM mouse monoclonal antibody (mAb)	1953
GMP-h-CA15-3-Ab02	Anti-human MUC1/CA15-3/PUM mouse monoclonal antibody (mAb)	1953
GMP-h-CA15-3-Ab03	Anti-human MUC1/CA15-3/PUM human monoclonal antibody (mAb)	1953
GMP-h-CA15-3-Ab04	Anti-human MUC1/CA15-3/PUM human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-h-CA15-3-Ag01
Product Name	Recombinant human MUC1/CA15-3/PUM Protein
Target/Biomarker	Cancer antigen 15-3 (CA15-3)
Alias of Target/Biomarker	ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM
Expression platform	mammalian
Isotypes	Recombinant Antigen
Bioactivity validation	Cancer antigen 15-3 (CA15-3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA15-3 level test of Cancer (breast cancer) and related syndrome evaluation.
Tag	His
Products description	Recombinant human MUC1/CA15-3/PUM Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-h-CA15-3-Ab01, GMP-h-CA15-3-Ab02
Product Name	Anti-human MUC1/CA15-3/PUM mouse monoclonal antibody (mAb)
Target/Biomarker	Cancer antigen 15-3 (CA15-3)
Alias of Target/Biomarker	ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Cancer antigen 15-3 (CA15-3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA15-3 level test of Cancer (breast cancer) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human MUC1/CA15-3/PUM mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-h-CA15-3-Ab03, GMP-h-CA15-3-Ab04
Product Name	Anti-human MUC1/CA15-3/PUM human monoclonal antibody (mAb)
Target/Biomarker	Cancer antigen 15-3 (CA15-3)
Alias of Target/Biomarker	ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Cancer antigen 15-3 (CA15-3) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CA15-3 level test of Cancer (breast cancer) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human MUC1/CA15-3/PUM human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Cancer antigen 15-3 (CA15-3) test Cancer antigen 15-3 (CA15-3) is a protein made by a variety of cells, particularly breast cancer cells. The protein moves into the blood, where it can be measured. CA15-3 levels are higher than normal in most women with breast cancer that has spread to other parts of the body (called metastatic breast cancer). Not all types of breast cancer will cause CA 15-3 levels to rise, as some types of cancer cells don’t over-produce the antigen. Why a CA15-3 test is done CA15-3 is a tumour marker. It is used to check how breast cancer treatment is working and look for cancer that has come back, or recurred, after treatment. If you are diagnosed with breast cancer that has spread to other parts of the body, or metastasized, you may have this test, along with other tests such as hormone receptor testing and HER2 status testing. CA15-3 is not measured for early stage breast cancer because the levels of this protein are rarely higher than normal at this stage.

About GDU